We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+9.94%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$24.1B
AUM Growth
-$134M
Cap. Flow
-$2.11B
Cap. Flow %
-8.76%
Top 10 Hldgs %
23.77%
Holding
1,984
New
527
Increased
347
Reduced
445
Closed
587

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$157M
2
TMO icon
Thermo Fisher Scientific
TMO
+$135M
3
CRM icon
Salesforce
CRM
+$135M
4
IBM icon
IBM
IBM
+$130M
5
DELL icon
Dell
DELL
+$114M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$313M
2
AAPL icon
Apple
AAPL
+$207M
3
INTC icon
Intel
INTC
+$183M
4
BMY icon
Bristol-Myers Squibb
BMY
+$159M
5
CNC icon
Centene
CNC
+$152M

Sector Composition

Rank Sector Weight
1 Healthcare 23.31%
2 Technology 17.95%
3 Communication Services 13.61%
4 Consumer Discretionary 12.67%
5 Financials 8.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OCGN icon
1376
Ocugen
OCGN
$434M
$131K ﹤0.01%
+16,328
New +$138K
STSA
1377
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$131K ﹤0.01%
+18,642
New +$101K
BHR
1378
Braemar Hotels & Resorts
BHR
$142M
$125K ﹤0.01%
+20,141
New +$124K
MRC
1379
DELISTED
MRC Global
MRC
$112K ﹤0.01%
+11,921
New +$121K
ACCO icon
1380
Acco Brands
ACCO
$407M
$102K ﹤0.01%
+11,817
New +$105K
CFFVW
1381
CALL
DELISTED
CF Acquisition Corp. V Warrant
CFFVW
$102K ﹤0.01%
+10,500
New +$9.1K
STPC.WS
1382
CALL
DELISTED
Star Peak Corp II Warrants, each whole warrant exercisable for one share of Class A common stock at
STPC.WS
$99K ﹤0.01%
10,000
– –
AEMD icon
1383
Aethlon Medical
AEMD
$1.66M
$98K ﹤0.01%
+5
New +$57.6K
NMG
1384
Nouveau Monde Graphite
NMG
$454M
$93K ﹤0.01%
+11,900
New +$126K
LSEA
1385
DELISTED
Landsea Homes
LSEA
$92K ﹤0.01%
+11,044
New +$100K
RFIL icon
1386
RF Industries
RFIL
$139M
$91K ﹤0.01%
+12,258
New +$86.6K
DBVT
1387
DBV Technologies
DBVT
$847M
$76K ﹤0.01%
1,388
-3,222
-70% -$193K
TOUR
1388
Tuniu
TOUR
$55.6M
$70K ﹤0.01%
2,982
-7,933
-73% -$217K
LTRPA
1389
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$68K ﹤0.01%
16,722
-210,036
-93% -$1.02M
UBX
1390
DELISTED
Unity Biotechnology
UBX
$67K ﹤0.01%
+1,440
New +$69.3K
MCF
1391
DELISTED
Contango Oil & Gas Co.
MCF
$64K ﹤0.01%
+14,859
New +$62.3K
TCDA
1392
DELISTED
Tricida, Inc. Common Stock
TCDA
$52K ﹤0.01%
12,014
– –
EXTN
1393
DELISTED
Exterran Corporation
EXTN
$48K ﹤0.01%
10,143
– –
SMTS
1394
DELISTED
Sierra Metals Inc. Common Stock
SMTS
$31K ﹤0.01%
10,200
-2,900
-22% -$9.6K
AAL icon
1395
American Airlines Group
AAL
$10.6B
– –
-9,191
Closed -$220K
AAP icon
1396
Advance Auto Parts
AAP
$3.49B
– –
-21,563
Closed -$3.96M
ABCL icon
1397
AbCellera Biologics
ABCL
$2.12B
– –
-77,638
Closed -$2.64M
ABUS icon
1398
Arbutus Biopharma
ABUS
$915M
– –
-235,951
Closed -$786K
ACAD icon
1399
Acadia Pharmaceuticals
ACAD
$5.03B
– –
-9,545
Closed -$246K
ACB
1400
Aurora Cannabis
ACB
$185M
– –
-3,220
Closed -$299K
54 55
56
57 58

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2021 Portfolio in Review

As of Q2 2021, Marshall Wace North America held 1,984 positions worth $24.1B, down 0.56% from $24.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Marshall Wace North America withdrew a net $2.11B in Q2 2021, closing 587 positions and reducing 445 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $119M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Marshall Wace North America opened a new position in Syneos Health, Inc. Class A Common Stock worth $83.7M.

  • Marshall Wace North America's largest Q2 2021 buy was Syneos Health, Inc. Class A Common Stock: 935,304 shares worth $83.7M.
  • Marshall Wace North America added most to Johnson & Johnson in Q2 2021, an estimated $157M increase.
  • Marshall Wace North America's biggest Q2 2021 reduction was Microsoft, cutting an estimated $313M.
  • Marshall Wace North America fully exited State Street SPDR S&P 500 ETF Trust in Q2 2021, selling an estimated $119M.
  • Marshall Wace North America's ten largest holdings make up 24% of its $24.1B portfolio in Q2 2021.
  • Marshall Wace North America opened 527 new positions and closed 587 in Q2 2021.
  • Marshall Wace North America's portfolio value fell 0.56% quarter-over-quarter to $24.1B.

Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.